ReviewDrugs2018

Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.

Pratima ChowdaryPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.